A surge in anti-dsDNA titer predicts a severe lupus flare within six months
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Objective: Rising anti-double-stranded (ds) DNA titers have been shown by some, but not all, studies to be predictive of disease flares in systemic lupus erythematosus (SLE). We hypothesized that a rapid and substantial rise in anti-dsDNA titer (anti-dsDNA surge) would be a good predictor of a clinically important SLE flare. Methods: A matched case-control study was conducted in an academic rheumatology practice setting. Our primary endpoint was the occurrence of a severe SELENA-SLEDAI (SS) flare within six months of an anti-dsDNA surge, and secondary endpoints were mild/moderate SS flares, as well as BILAG A and B renal flares. Cases were identified as those patients whose disease course included a surge of anti-dsDNA, defined as an increase of anti-dsDNA titer by the Crithidia luciliae immunofluorescence (CLIF) assay from 0 to 3+/4+, or from 1+ to 4+, within a period of less than 12 months. The date of the anti-dsDNA surge was defined as Day 0. Two control SLE patients were identified for each case and were matched for age, sex, race, and visit date closest to case Day 0, but without an anti-dsDNA surge. Logistic regression models were used to detect associations between anti-dsDNA surges and severe SS flares. Result: A higher proportion of cases, compared to controls, experienced a severe SS flare within six months of Day 0 (OR 6.3 (95% confidence intervals 2.0–19.9), p = 0.02). Associations with all flares and hospitalizations for flares were also observed. However, an anti-dsDNA surge was not predictive of a renal flare. Conclusion: An anti-dsDNA surge predicts the subsequent development of a severe SS flare within six months. Physicians should closely monitor such patients and treat promptly at the first sign of clinical activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antibodies to dsDNA are an important laboratory parameter for diagnosis, monitoring and classification of systemic lupus erythematosus (SLE).”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [11]
Citations
Cites
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
Arbuckle, M. R., McClain, M. T., Rubertone, M. V., Scofield, R. H., Dennis, G. J., James, J. A., & Harley, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021933 · Cited by 2,578
Hahn, B. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805073381906 · Cited by 682
Buyon, J. P., Petri, M. A., Kim, M. Y., Kalunian, K. C., Grossman, J., Hahn, B. H., Merrill, J. T., Sammaritano, L., Lockshin, M., Alarcón, G. S., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-12_part_1-200506210-00004 · Cited by 661
Isenberg, D. A., Rahman, A., Allen, E., Farewell, V., Akil, M., Bruce, I. N., D'Cruz, D., Griffiths, B., Khamashta, M., Maddison, P., et al. (2005) · Rheumatology · doi:10.1093/rheumatology/keh624 · Cited by 636
Ter Borg, E. J., Horst, G., Hummel, E. J., Limburg, P. C., & Kallenberg, C. G. M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330505 · Cited by 572
Petri, M., Genovese, M., Engle, E., & Hochberg, M. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340802 · Cited by 340
Prevention of relapses in systemic lupus erythematosus
Bootsma, H., Spronk, P., de Boer, G., Limburg, P., Kallenberg, C., Derksen, R., Wolters-Dicke, J., Gmelig-Meyling, F., Kater, L., & Hermans, J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90114-0 · Cited by 290
Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti‐DNA antibody tests
Kavanaugh, A. F., Solomon, D. H., & The American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines (2002) · Arthritis Care & Research · doi:10.1002/art.10558 · Cited by 225
Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus.
Swaak, A. J., Groenwold, J., & Bronsveld, W. (1986) · Annals of the Rheumatic Diseases · doi:10.1136/ard.45.5.359 · Cited by 224
Linnik, M. D., Hu, J. Z., Heilbrunn, K. R., Strand, V., Hurley, F. L., Joh, T., & LJP 394 Investigator Consortium (2005) · Arthritis & Rheumatism · doi:10.1002/art.20980 · Cited by 209
Cited by
The Diagnosis and Treatment of Systemic Lupus Erythematosus
Kuhn, A., Bonsmann, G., Anders, H.-J., Herzer, P., Tenbrock, K., & Schneider, M. (2015) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2015.0423 · Cited by 230
Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies
Wang, X., & Xia, Y. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01667 · Cited by 182
“Tests for anti-DNA antibodies can be positive at least 2 years before clinical diagnosis of SLE, and a surge in serum levels can present as a predictor for a severe SLE flare-up in the following 6 months (57).”
BackgroundPredictive biological markers of systemic lupus erythematosus flares: a systematic literature review
ACRONIM, O. B. O. T. F., Gensous, N., Marti, A., Barnetche, T., Blanco, P., Lazaro, E., Seneschal, J., Truchetet, M.-E., Duffau, P., & Richez, C. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1442-6 · Cited by 99
“1% [28] to 59% [25] and negative predictive value (NPV) from 67% [26] to 97.”
BackgroundMethodInfluentialFranco, A. S., Freitas, T. Q., Bernardo, W. M., & Pereira, R. M. R. (2017) · Medicine · doi:10.1097/md.0000000000007024 · Cited by 112
Floris, A., Piga, M., Cauli, A., & Mathieu, A. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.02.019 · Cited by 74
Metadata
- Authors
- Pan, N., Amigues, I., Lyman, S., Duculan, R., Aziz, F., Crow, M., & Kirou, K.
- Affiliations
- Hospital for Special Surgery (US)
- St. Luke's-Roosevelt Hospital Center (US)
- University of Florida Health (US)
- Hospital for Special Surgery, Division of Rheumatology, NY, USA
- Venue
- Lupus
- Publisher
- SAGE Publications
- Published
- 2013-12-06
- Volume
- 23
- Issue
- 3
- Pages
- 293-298
- ISSN
- 0961-2033 (ISSN-L)
- 1477-0962
- OpenAlex
- W1968816450
- Semantic Scholar
- 105caa51de088d0152b4c099fcb0f187b954c749
- Cited by
- 59
- References
- 13
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 4 · 2021: 5 · 2020: 2 · 2019: 5 · 2018: 6 · 2017: 2 · 2016: 5 · 2015: 4 · 2014: 2
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Lupus (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- systemic lupus erythematosus, anti-dsDNA antibodies, disease flare prediction, SELENA-SLEDAI, renal flares, antibody titer monitoring
- MeSH terms
- Academic Medical Centers, Adult, Antibodies, Antinuclear, DNA, Female, Fluorescent Antibody Technique, Humans, Lupus Erythematosus, Systemic, Lupus Nephritis, Male, Middle Aged, Predictive Value of Tests, Registries, Retrospective Studies, Severity of Illness Index, Time Factors, Biomarkers, Up-Regulation, Chi-Square Distribution, Logistic Models, Odds Ratio, Disease Progression, Kaplan-Meier Estimate, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A surge in anti-dsDNA titer predicts a severe lupus flare within six months. https://app.cochat.ai/papers/10.1177/0961203313515763
- The paper
- Pan, N., Amigues, I., Lyman, S., Duculan, R., Aziz, F., Crow, M., & Kirou, K. (2014). A surge in anti-dsDNA titer predicts a severe lupus flare within six months. Lupus. https://doi.org/10.1177/0961203313515763
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.